Brucella prosthetic valve endocarditis with septic and cardiogenic shock

A young man with aortic prosthetic valve replacement, presented with prolonged fever and diagnosed with brucella endocarditis based on positive transthoracic echo findings with high titer positive brucellacapt serology. He was started on medical treatment with doxycycline and rifampin to which genta...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamieh, Amal, Hamieh, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347979/
https://www.ncbi.nlm.nih.gov/pubmed/32670791
http://dx.doi.org/10.1016/j.idcr.2020.e00881
_version_ 1783556697851166720
author Hamieh, Amal
Hamieh, Mohamad
author_facet Hamieh, Amal
Hamieh, Mohamad
author_sort Hamieh, Amal
collection PubMed
description A young man with aortic prosthetic valve replacement, presented with prolonged fever and diagnosed with brucella endocarditis based on positive transthoracic echo findings with high titer positive brucellacapt serology. He was started on medical treatment with doxycycline and rifampin to which gentamicin and ceftriaxone were added and he was planned for surgical intervention. Unfortunately, the patient developed cardiogenic with septic shock before performing surgery and died within 24 h soon after admission.
format Online
Article
Text
id pubmed-7347979
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73479792020-07-14 Brucella prosthetic valve endocarditis with septic and cardiogenic shock Hamieh, Amal Hamieh, Mohamad IDCases Article A young man with aortic prosthetic valve replacement, presented with prolonged fever and diagnosed with brucella endocarditis based on positive transthoracic echo findings with high titer positive brucellacapt serology. He was started on medical treatment with doxycycline and rifampin to which gentamicin and ceftriaxone were added and he was planned for surgical intervention. Unfortunately, the patient developed cardiogenic with septic shock before performing surgery and died within 24 h soon after admission. Elsevier 2020-06-20 /pmc/articles/PMC7347979/ /pubmed/32670791 http://dx.doi.org/10.1016/j.idcr.2020.e00881 Text en © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Hamieh, Amal
Hamieh, Mohamad
Brucella prosthetic valve endocarditis with septic and cardiogenic shock
title Brucella prosthetic valve endocarditis with septic and cardiogenic shock
title_full Brucella prosthetic valve endocarditis with septic and cardiogenic shock
title_fullStr Brucella prosthetic valve endocarditis with septic and cardiogenic shock
title_full_unstemmed Brucella prosthetic valve endocarditis with septic and cardiogenic shock
title_short Brucella prosthetic valve endocarditis with septic and cardiogenic shock
title_sort brucella prosthetic valve endocarditis with septic and cardiogenic shock
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347979/
https://www.ncbi.nlm.nih.gov/pubmed/32670791
http://dx.doi.org/10.1016/j.idcr.2020.e00881
work_keys_str_mv AT hamiehamal brucellaprostheticvalveendocarditiswithsepticandcardiogenicshock
AT hamiehmohamad brucellaprostheticvalveendocarditiswithsepticandcardiogenicshock

Ejemplares similares